Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy R Cook

Showing results (41-50 of 368) with videos related to

Pageof 37
Sort By:
American Journal of Epidemiology|May 30, 2002
Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health StudyNancy R Cook, Stephen R Cole, Charles H Hennekens
Journal of Clinical Hypertension (Greenwich, Conn.)|November 4, 2018
Weight change and mortality: Long-term results from the trials of hypertension preventionNancy R Cook, Lawrence J Appel, Paul K Whelton
Hypertension (Dallas, Tex. : 1979)|July 17, 2013
Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008Bernard Rosner, Nancy R Cook, Stephen Daniels, et al.
JAMA|October 11, 2018
Meta-analysis of LDL-C Lowering and MortalityEdward K Duran, Nancy R Cook, Paul M Ridker
Statistics in Medicine|November 21, 2017
Clinical risk reclassification at 10 yearsNancy R Cook, Olga V Demler, Nina P Paynter
Statistics in Medicine|February 17, 2015
Tests of calibration and goodness-of-fit in the survival settingOlga V Demler, Nina P Paynter, Nancy R Cook
European Journal of Epidemiology|June 16, 2012
Aspirin in the primary prevention of cardiovascular disease in the Women's Health Study: effect of noncomplianceNancy R Cook, Stephen R Cole, Julie E Buring
JAMA|July 27, 2006
Use of aspirin as primary prevention of cardiovascular eventsPaul M Ridker, Nancy R Cook, Julie E Buring
Diagnostic and Prognostic Research|April 16, 2019
Reclassification calibration test for censored survival data: performance and comparison to goodness-of-fit criteriaOlga V Demler, Nina P Paynter, Nancy R Cook
Clinical Chemistry|October 9, 2013
Cardiovascular disease risk prediction in women: is there a role for novel biomarkers?Nina P Paynter, Brendan M Everett, Nancy R Cook
Pageof 37

Showing results (41-50 of 368) with videos related to

Sort By:
Pageof 37
American Journal of Epidemiology|May 30, 2002
Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health StudyNancy R Cook, Stephen R Cole, Charles H Hennekens
Journal of Clinical Hypertension (Greenwich, Conn.)|November 4, 2018
Weight change and mortality: Long-term results from the trials of hypertension preventionNancy R Cook, Lawrence J Appel, Paul K Whelton
Hypertension (Dallas, Tex. : 1979)|July 17, 2013
Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008Bernard Rosner, Nancy R Cook, Stephen Daniels, et al.
JAMA|October 11, 2018
Meta-analysis of LDL-C Lowering and MortalityEdward K Duran, Nancy R Cook, Paul M Ridker
Statistics in Medicine|November 21, 2017
Clinical risk reclassification at 10 yearsNancy R Cook, Olga V Demler, Nina P Paynter
Statistics in Medicine|February 17, 2015
Tests of calibration and goodness-of-fit in the survival settingOlga V Demler, Nina P Paynter, Nancy R Cook
European Journal of Epidemiology|June 16, 2012
Aspirin in the primary prevention of cardiovascular disease in the Women's Health Study: effect of noncomplianceNancy R Cook, Stephen R Cole, Julie E Buring
JAMA|July 27, 2006
Use of aspirin as primary prevention of cardiovascular eventsPaul M Ridker, Nancy R Cook, Julie E Buring
Diagnostic and Prognostic Research|April 16, 2019
Reclassification calibration test for censored survival data: performance and comparison to goodness-of-fit criteriaOlga V Demler, Nina P Paynter, Nancy R Cook
Clinical Chemistry|October 9, 2013
Cardiovascular disease risk prediction in women: is there a role for novel biomarkers?Nina P Paynter, Brendan M Everett, Nancy R Cook
Pageof 37